- Home
- MNDY vs BMRN Comparison
MNDY vs BMRN Comparison
Compare MNDY & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDY
- BMRN
- Stock Information
- Founded
- MNDY 2012
- BMRN 1996
- Country
- MNDY Israel
- BMRN United States
- Employees
- MNDY N/A
- BMRN N/A
- Industry
- MNDY Computer Software: Prepackaged Software
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MNDY Technology
- BMRN Health Care
- Exchange
- MNDY Nasdaq
- BMRN Nasdaq
- Market Cap
- MNDY 14.7B
- BMRN 12.1B
- IPO Year
- MNDY 2021
- BMRN 1999
- Fundamental
- Price
- MNDY $302.98
- BMRN $55.65
- Analyst Decision
- MNDY Strong Buy
- BMRN Buy
- Analyst Count
- MNDY 25
- BMRN 22
- Target Price
- MNDY $345.32
- BMRN $93.43
- AVG Volume (30 Days)
- MNDY 468.8K
- BMRN 2.2M
- Earning Date
- MNDY 08-11-2025
- BMRN 08-04-2025
- Dividend Yield
- MNDY N/A
- BMRN N/A
- EPS Growth
- MNDY 145.64
- BMRN 152.82
- EPS
- MNDY 1.00
- BMRN 2.71
- Revenue
- MNDY $1,037,332,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- MNDY $28.40
- BMRN $12.23
- Revenue Next Year
- MNDY $23.24
- BMRN $9.99
- P/E Ratio
- MNDY $302.87
- BMRN $20.77
- Revenue Growth
- MNDY 32.25
- BMRN 19.36
- 52 Week Low
- MNDY $188.01
- BMRN $52.93
- 52 Week High
- MNDY $342.64
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- MNDY 59.27
- BMRN 40.03
- Support Level
- MNDY $293.83
- BMRN $53.76
- Resistance Level
- MNDY $316.98
- BMRN $55.96
- Average True Range (ATR)
- MNDY 10.88
- BMRN 1.17
- MACD
- MNDY 1.26
- BMRN 0.09
- Stochastic Oscillator
- MNDY 82.77
- BMRN 26.00
About MNDY monday.com Ltd.
Monday.com is a provider of work management software delivered via a cloud-based software-as-a-service, or SaaS model. The firm's solutions offer flexible and highly customizable tools to digitize business processes across countless use cases. Monday's offering supports workflow management across departments, real-time visibility and accountability, and automation capabilities. Monday also offers prepackaged CRM and DevOps management solutions, in addition to standalone survey and digital whiteboard tools. As of 2023, Monday served over 225,000 customers in more than 200 countries.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.